Gold futures dropped from its record highs on Thursday morning at London’s trading session as global investors retreated from the safe-haven asset as their appetite for riskier financial assets surge.
Gold futures were slightly down 0.02% to trade at $1,779 at 9:03 am Nigerian time, after losing more than 1% yesterday at America’s trading session.
Stephen Innes, Chief Global Market Strategist at AxiCorp in a note to Nairametrics spoke about the macros, affecting Gold as an asset. He said:
“Gold price got hammered lower after the vaccine headlines but have since stabilized and are ticking gingerly higher. A vaccine would be significant.
“However, I do not think it’s immediately or radically changing many house views on gold, which are mostly predicated on the long and bumpy road to economic recovery.
“But the next couple of weeks may tell us much about how the rest of the pandemic develops.
“Gold is still very well bid as the US remains mired amid crises, a health crisis, and a political crisis. The intense polarization of US political life and the outbreak of racial friction is making the implementation of a consistent and wide-sweeping health care policy difficult.
“Sure, a vaccine would be the ultimate salvation, but by current indications and in the absence of one, it will take longer for the US to fight off the virus than other developed economies.
Although the precious metal possesses some upside, with the present market volatility on-going, coupled with the resurgence of COVID-19 cases around the world prompting the World Health Organization to issue a stern warning yesterday, that reinstatement of lockdown measures could be required in some geopolitical zones
Brent Crude price trades at $45 per barrel, as fuel demand picks up
Brent crude held most of it gains from the previous trading session.
Brent Crude oil prices dropped slightly at Asia’s trading session.
Brent crude prices held most of it gains from the previous trading session after U.S. government data showed a fall in U.S Crude Stockpiles supporting the view that fuel demand is picking up despite the COVID-19 pandemic.
Brent crude was slightly down by 0.07% to trade at $45.40 a barrel by 04.32 GMT, after a gain of around 2% in the previous session.
Quick fact: Brent crude is the leading global benchmark for Atlantic basin crude oil. The international benchmark is used to set the price of crude oil of about two-thirds of the world’s traded crude oil including Nigeria’s crude.
However, Stephen Innes, Chief Global Market Strategist at AxiCorp in a note to Nairametrics, revealed vital macros, that could keep crude oil relatively stable in the coming days. He said;
“But even worries around stalled US fiscal talks are partly offset by the US administration’s conciliatory tone on China’s compliance with the ‘Phase One’ trade deal.
“The upcoming six-month assessment seems unlikely to prompt any significant fireworks. Also, investor’s optimism remains high on a vaccine cure that is no longer being viewed as a pie in the sky.
“Finally, the US dollar’s weakness helps Oil prices in general, but even more so in this environment, as the weaker US dollar reflects a global “risk-on” environment, not a flagging US economy. “
Download the Nairametrics News App
Global COVID-19 cases now exceed 20 million, so in the absence of meaningful progress on a COVID-19 vaccine, traders are still looking over their shoulders to where new lockdowns might be necessary.
Gold prices drop below $1,900 after U.S dollar strengthens
The plunge came as appetite for risk assets recovered thanks to a stronger greenback and real rates.
Gold prices dropped sharply on Wednesday at London’s trading session. Gold futures were down 2.69% to trade at about $1,893.20 as at the time this report was drafted.
The plunge came as appetite for risk assets recovered, thanks to a stronger greenback and real rates. The U.S dollar is up on Wednesday, continuing to rise from its two-year lows.
The present huge sell-offs recorded in the precious metal market astonished many gold traders after the per-ounce price of the yellow metal plunged below $1,900.
Here’s an Insight: Stephen Innes, Chief Global Market Strategist at AxiCorp, in a note to Nairametrics, explained the macros, giving Gold bears such strength, as the precious metal continues its sudden downward trend. He said;
“The real pain trade gold as swollen positions got hit with the truncheon, and gold plunged the most in seven years as the bottom fell out of the markets with US Treasuries and bunds bear-steepening and real yields higher.
“Gold markets sold off picking speed exponentially as freshly minted gold longs ran for the exit.
“And in typical low liquidity August fashion, market makers were merciless pounding gold to within a hair’s breadth of $1900 as the steam roller got heading downhill when the afternoon Shanghai session saw waves of Asia banks selling en masse.”
Whether or not gold can regain its previous highs will depend on whether there is more room for downside in real yields or more dovish policies by the US Federal Reserve. Still, the possibility of squeezy price action remains in play after the US Bond market sent out the most explicit warning last week.
Gold price loses $80 following Russia’s COVID-19 vaccine approval
This marks gold’s steepest daily decline in nearly five months.
Gold futures have lost about 5% or $80 in less than four hours, at the London trading session this afternoon.
Gold futures fell as low as $1,950 per ounce, $80 differential from its opening price of $2,030
This marks gold’s steepest daily decline in nearly five months, even as global stocks went bullish following news that Russia’s COVID-19 vaccine has obtained regulatory approval.
The COVID-19 vaccine approval by Russia was met with some skepticism by experts.
Russian President Vladimir Putin announced on Tuesday that a locally developed vaccine for COVID-19, Sputnik-V, has been given regulatory approval and is ready for use.
Russian Health Minister Mikhail Murashko said that the vaccine had “proven to be highly effective and safe”, with mass vaccination planned to start in October.
But health regulators elsewhere have cast doubts on the vaccine, as it has not yet gone through safety trials and Russia did not offer any scientific evidence of the vaccine’s effectiveness and safety.